Opinion: Premature regulatory approval by the FDA

Addition of platinum to standard neoadjuvant chemotherapy improves EFS in patients with TNMBC

HER2DX confirms the ability of the test to predict long-term survival and response to anti-HER2 therapy in BC

Treatment decision guided by CTC count may improve long-term outcomes for mBC

Access to Oncology Medicines Coalition - The Medicines Patent Pool

Intraoperative ultrasound is accurate for guiding breast conservative surgery in non-palpable ductal breast carcinoma

Addressing women’s cancers: an economic evaluation of breast and cervical cancer interventions in Kenya

Long-term breast cancer risk after benign breast disease in population-based screening

EPIC study: Pre-existing cardiometabolic diseases impact cancer stage

Individualised breast cancer risk assessment model for BreastScreen Norway

Choosing wisely: Breast cancer

Complex technologies for advanced diagnosis and precision medicine in oncology